Neonatal Sepsis: Mortality and Morbidity in Neonatal Sepsis due to Multidrug-Resistant (MDR) Organisms: Part 1

Indian J Pediatr. 2020 Feb;87(2):117-121. doi: 10.1007/s12098-019-03106-z. Epub 2019 Dec 11.

Abstract

The major causes of emergence of multidrug-resistant organisms (MDRO) in neonatal sepsis include empiric antibiotic prescriptions, unregulated use of over-the-counter drugs, high incidence of healthcare associated infections (HAI), lack of awareness about antibiotic stewardship program and under staffing of neonatal intensive care units. In general, mortality due to MDRO sepsis is significantly higher as compared to non MDRO sepsis. Reported morbidities include prolonged use of total parenteral nutrition, need for central venous catheter, invasive ventilation, increased duration of hospital stay and neurologic sequelae.

Keywords: Financial burden; MDR; Morbidity; Mortality; Neonatal sepsis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Cross Infection / drug therapy
  • Cross Infection / mortality
  • Drug Resistance, Multiple / drug effects*
  • Humans
  • India / epidemiology
  • Infant, Newborn
  • Intensive Care Units, Neonatal
  • Length of Stay
  • Microbial Sensitivity Tests
  • Morbidity*
  • Neonatal Sepsis / drug therapy*
  • Neonatal Sepsis / mortality*
  • Risk Factors

Substances

  • Anti-Bacterial Agents